![Julien Alberici](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julien Alberici
Verkställande Direktör på
Mathym SAS
Profil
Julien Alberici is the founder.
Founded Mathym SAS in 2013 as Chief Executive Officer.
Current job at Octalfa SAS since 2013 as CEO.
Current job at ORPHELIA Pharma SAS as Director.
Former job at Baikowski SA as Director-Business Development.
Aktiva positioner av Julien Alberici
| Företag | Position | Start |
|---|---|---|
Octalfa SAS
 Octalfa SAS Investment ManagersFinance Octalfa is a hands-on investor who plays an active role in their portfolio companies and seeks board representation. The firm focuses on early-stage businesses including seed-stage projects in the life sciences sectors, and may also co-invest in later-stage companies. Octalfa invests from their own balance sheet, in the EUR 500 thousand to 1.5 million range, as a one-time investor or over several financing rounds. | Administrativ Direktör | 2013-01-01 |
Mathym SAS
 Mathym SAS Miscellaneous Commercial ServicesCommercial Services Manufacutures and developps innovative colloïdal solutions. | Verkställande Direktör | 2013-09-01 |
ORPHELIA Pharma SAS
 ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology Specializes on biopharmaceutical products improving the health and well being of severely disabled children | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Julien Alberici
| Företag | Position | Slut |
|---|---|---|
| BAIKOWSKI | Företagsledare/Principal | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
8
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Octalfa SAS
Octalfa SAS Investment ManagersFinance Octalfa is a hands-on investor who plays an active role in their portfolio companies and seeks board representation. The firm focuses on early-stage businesses including seed-stage projects in the life sciences sectors, and may also co-invest in later-stage companies. Octalfa invests from their own balance sheet, in the EUR 500 thousand to 1.5 million range, as a one-time investor or over several financing rounds. | Finance |
Mathym SAS
Mathym SAS Miscellaneous Commercial ServicesCommercial Services Manufacutures and developps innovative colloïdal solutions. | Commercial Services |
Baikowski SA
 Baikowski SA Chemicals: SpecialtyProcess Industries Produces and supplies alumina powders, phosphors & formulations | Process Industries |
ORPHELIA Pharma SAS
ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology Specializes on biopharmaceutical products improving the health and well being of severely disabled children | Health Technology |
